MA42367A - PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGES OF THE RECTUM - Google Patents

PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGES OF THE RECTUM

Info

Publication number
MA42367A
MA42367A MA042367A MA42367A MA42367A MA 42367 A MA42367 A MA 42367A MA 042367 A MA042367 A MA 042367A MA 42367 A MA42367 A MA 42367A MA 42367 A MA42367 A MA 42367A
Authority
MA
Morocco
Prior art keywords
rectum
treatment
pharmaceutical formulation
inflammatory changes
inflammatory
Prior art date
Application number
MA042367A
Other languages
French (fr)
Other versions
MA42367B1 (en
Inventor
Roland Greinwald
Ralf Mohrbacher
Markus Pröls
Rudolph Wilhelm
Original Assignee
Dr Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Falk Pharma Gmbh filed Critical Dr Falk Pharma Gmbh
Publication of MA42367A publication Critical patent/MA42367A/en
Publication of MA42367B1 publication Critical patent/MA42367B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA42367A 2015-07-08 2016-06-28 Pharmaceutical formulation for the treatment of inflammatory rectal changes MA42367B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15175806.7A EP3115037B1 (en) 2015-07-08 2015-07-08 Pharmaceutical preparations for the treatment of inflammatory conditions of the rectum
PCT/EP2016/064907 WO2017005524A1 (en) 2015-07-08 2016-06-28 Pharmaceutical formulation for the treatment of inflammatory changes to the rectum

Publications (2)

Publication Number Publication Date
MA42367A true MA42367A (en) 2018-05-16
MA42367B1 MA42367B1 (en) 2023-02-28

Family

ID=53540667

Family Applications (1)

Application Number Title Priority Date Filing Date
MA42367A MA42367B1 (en) 2015-07-08 2016-06-28 Pharmaceutical formulation for the treatment of inflammatory rectal changes

Country Status (23)

Country Link
US (3) US10905699B2 (en)
EP (2) EP3115037B1 (en)
JP (1) JP6857644B2 (en)
CN (1) CN107847435B (en)
AU (1) AU2016290343B2 (en)
CA (1) CA2986081C (en)
DK (1) DK3319586T3 (en)
EA (1) EA033153B1 (en)
ES (2) ES2688119T3 (en)
FI (1) FI3319586T3 (en)
HR (1) HRP20230174T1 (en)
HU (1) HUE061585T2 (en)
IL (1) IL255247B (en)
LT (1) LT3319586T (en)
MA (1) MA42367B1 (en)
MD (1) MD3319586T2 (en)
PL (1) PL3319586T3 (en)
PT (2) PT3115037T (en)
RS (1) RS64020B1 (en)
SI (1) SI3319586T1 (en)
UA (1) UA120075C2 (en)
WO (1) WO2017005524A1 (en)
ZA (1) ZA201707777B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022226778A1 (en) * 2021-04-27 2022-11-03 广州共禾医药科技有限公司 Rectally administered pharmaceutical composition containing oseltamivir or pharmaceutically acceptable salt thereof, and preparation method therefor and use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB701831A (en) * 1950-10-19 1954-01-06 Rudolf Von Wuelfing Process for the production of suppositories containing medicaments
US3208907A (en) * 1961-11-13 1965-09-28 Lab Toraude Stabilized salicylate compositions
DE3709861A1 (en) * 1987-03-25 1988-10-06 Henkel Kgaa EMULSIFYING SUPPOSITORIES AND MEASURES PRODUCED FROM THEM
JP2927830B2 (en) * 1989-09-01 1999-07-28 東京田辺製薬株式会社 Danazol suppository
IT1243379B (en) 1990-07-27 1994-06-10 Giuliani Spa PHARMACEUTICAL COMPOSITION SUITABLE FOR RECTAL ADMINISTRATION OF ACTIVE PRINCIPLES WHICH EXPLICATE A MEDICATION ACTION AT THE LEVEL OF THE COLON, PREVALENTLY TOPICAL
DE29717252U1 (en) * 1997-09-26 1998-02-19 Dr. Falk Pharma GmbH, 79108 Freiburg Drug kit consisting of a budesonide-containing and an ursodeoxycholic acid-containing drug for the treatment of cholestatic liver diseases
DE19849737A1 (en) * 1998-10-28 2000-05-04 Falk Pharma Gmbh Combination agent for the treatment of inflammatory bowel disease
US20020085978A1 (en) * 2000-11-10 2002-07-04 Mina Buenafe Degradation-resistant glucocorticosteroid formulations
CU23203A1 (en) * 2002-12-27 2007-05-18 Ct Ingenieria Genetica Biotech FORMULATIONS CONTAINING AGENTS OF TROMBOLITIC ACTION FOR ADMINISTRATION BY RECTAL ROUTE
JP5223307B2 (en) * 2006-11-17 2013-06-26 大正製薬株式会社 Suppository
EP2392321A1 (en) * 2007-06-13 2011-12-07 Jay Pravda Combined composition for rectal administration for the treatment of inflammatory bowel disease
CN102316889B (en) * 2008-11-26 2014-11-26 萨蒂奥根制药公司 Compositions containing satiogens and methods of use
WO2012022796A2 (en) * 2010-08-20 2012-02-23 Boehringer Ingelheim International Gmbh Novel combinations
CN102525883B (en) * 2010-12-09 2013-05-08 丽珠集团丽珠制药厂 Voriconazole suppository and preparation method and application thereof
WO2015073846A1 (en) 2013-11-15 2015-05-21 Salix Pharmaceuticals, Inc. Method of treating ulcerative colitis

Also Published As

Publication number Publication date
US10905699B2 (en) 2021-02-02
AU2016290343B2 (en) 2020-10-15
EA033153B1 (en) 2019-09-30
MA42367B1 (en) 2023-02-28
US20230364113A1 (en) 2023-11-16
CN107847435A (en) 2018-03-27
HUE061585T2 (en) 2023-07-28
PT3319586T (en) 2023-02-14
PT3115037T (en) 2018-10-22
UA120075C2 (en) 2019-09-25
EP3319586B1 (en) 2023-01-18
JP6857644B2 (en) 2021-04-14
EP3115037A1 (en) 2017-01-11
US20210100819A1 (en) 2021-04-08
DK3319586T3 (en) 2023-02-27
ZA201707777B (en) 2018-11-28
PL3319586T3 (en) 2023-05-08
IL255247B (en) 2020-11-30
RS64020B1 (en) 2023-03-31
WO2017005524A1 (en) 2017-01-12
CA2986081A1 (en) 2017-01-12
LT3319586T (en) 2023-03-10
JP2018519345A (en) 2018-07-19
US20180200268A1 (en) 2018-07-19
ES2688119T3 (en) 2018-10-31
US11738032B2 (en) 2023-08-29
CA2986081C (en) 2024-02-20
ES2938358T3 (en) 2023-04-10
EP3115037B1 (en) 2018-08-15
IL255247A0 (en) 2017-12-31
EA201792685A1 (en) 2018-07-31
FI3319586T3 (en) 2023-03-22
MD3319586T2 (en) 2023-04-30
NZ736749A (en) 2023-12-22
SI3319586T1 (en) 2023-03-31
CN107847435B (en) 2021-07-27
HRP20230174T1 (en) 2023-04-14
AU2016290343A1 (en) 2017-11-16
EP3319586A1 (en) 2018-05-16

Similar Documents

Publication Publication Date Title
MA49144A (en) POLYTHERAPIES FOR THE TREATMENT OF CANCER
MA45146A (en) PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER
FR3046933B1 (en) NLRP3 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
MA43746A (en) 2-CYANOISOINDOLINE DERIVATIVES FOR THE TREATMENT OF CANCER
MA43135A (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
MA45481A (en) USE OF EXOSOMES FOR THE TREATMENT OF DISEASES
MA42420A (en) VACCINES FOR THE TREATMENT AND PREVENTION OF CANCER
MA43283A (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
MA48637A (en) POLYTHERAPIES FOR THE TREATMENT OF CANCER
MA55629A (en) ANTIBODY COMPOSITIONS FOR THE TREATMENT OF TUMORS
MA39748A (en) CENICRIVIROC FOR THE TREATMENT OF FIBROSIS
MA41449A (en) POLYTHERAPIES FOR THE TREATMENT OF CANCERS
MA50409A (en) POLYTHERAPIES FOR THE TREATMENT OF CANCER
MA47719A (en) ESKETAMINE FOR THE TREATMENT OF DEPRESSION
MA54925A (en) COMPOSITIONS FOR THE TREATMENT OF ACID-BASED DISORDERS
MA41299A (en) OPHTHALMIC SOLUTIONS FOR THE TREATMENT OF GLAUCOMA AND CONJUNCTIVITIS
MA45429A (en) POLYTHERAPY FOR CANCER TREATMENT
FR3032353B1 (en) PHARMACEUTICAL COMPOSITION AND DEVICE FOR THE TREATMENT OF PAIN
MA42999A (en) POLYTHERAPY FOR THE TREATMENT OF MALIGNITIES
MA41555A (en) POLYTHERAPY FOR CANCER TREATMENT
MA53568A (en) DRUGS FOR THE TREATMENT OF OPHTHALMIC DISEASES
FR3017298B1 (en) CONJUGATES AND PRO-DRUGS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES
MA45973A (en) BTK INHIBITOR COMBINATIONS FOR THE TREATMENT OF MULTIPLE MYELOMA
MA52499A (en) CANCER TREATMENT ASSOCIATIONS
FR3022139B1 (en) NEW COMPOSITIONS FOR THE TREATMENT OF SKIN FLAVORS AND ROSACEA